HEFT 1/2024
Der Merkurstab | Januar/Februar 2024 | 18,00 Euro (inkl. Mwst., zzgl. Versandkosten)
| Artikel | Case cluster of RT-PCR COVID-19 positive patients with an unexpected benign clinical course with vitamin D, melatonin, vitamin C, and Viscum album |
| Autoren | Mark Hancock, Petra Ketterl, Xavier Vinas, Paul Werthmann |
| Seiten | 006-012 |
| Volume | 77 |
Zusammenfassung
Background: The SARS-CoV-2 global pandemic has
been noted to have a differential effect on those
exposed depending on risk factors such as age,
diabetes, cardiovascular disease and cancer.
Case presentation:We report a case series of 12 confirmed
positive patients and 12 presumptive positive
patients all of whom had either an entirely asymptomatic
or relatively mild clinical course. 2 patients
had active cancer, 3 patients were cancer survivors,
1 patient without cancer was 74 years old. All patients
were treated early in their disease course with vitamin
D loading (50,000 IU daily for 3 days), 60 to 240
mg melatonin, and 2000 mg oral vitamin C. The 6
high risk patients and one 59 year old patient were
treated with at least 2 intravenous doses of vitamin C.
The 2 patients with active cancer received 75 grams
of vitamin C (one daily, the other every other day). All
of the high risk patients had a nearly asymptomatic
clinical course and were tested after 10 days and all
had a RT PCR for COVID-19 that was negative. The 17
remaining patients also had a relatively benign
course though 4 patients (2 in their 20s, 2 in their 50s)
received this treatment course later in the course of
their illness. These were notably the only patients
who had more than a mild sore throat or low grade
fever.
Conclusion:We report these unexpectedly positive
clinical outcomes of COVID-19 patients including patients
with different risk factors, under supplemental
vitamin C and D and melatonin. These supplements
have a favorable safety profile and are already being
suggested as potentially disease altering therapies in
the COVID-19 pandemic.
